Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.528NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.175NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.6.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.483NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.181NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.113NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.594NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.328NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.13NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.214NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.284NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.351.3 (Beta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.318NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
R.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.29 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
ML.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.283NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.118NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.501NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.226NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.546NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.194NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.429.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.9 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.25.1.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.203NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.157NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.176NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.3.4 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.391NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.393NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.432NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.388NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.48NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.112NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.274NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-2770.32China
B.1.515NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.111NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.27NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.19NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.336NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.400.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.537NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.548NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.24.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.492NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used